Anterix (NASDAQ:ATEX) Director Leslie Daniels Sells 4,100 Shares

Anterix Inc. (NASDAQ:ATEXGet Free Report) Director Leslie Daniels sold 4,100 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $87.07, for a total value of $356,987.00. Following the sale, the director owned 45,977 shares of the company’s stock, valued at approximately $4,003,217.39. The trade was a 8.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Anterix Trading Down 1.0%

Shares of Anterix stock traded down $0.83 during trading hours on Tuesday, reaching $85.44. The stock had a trading volume of 229,616 shares, compared to its average volume of 389,373. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of 24.41 and a beta of 0.84. Anterix Inc. has a 1 year low of $17.58 and a 1 year high of $113.00. The firm has a 50 day simple moving average of $96.30 and a two-hundred day simple moving average of $67.33.

Anterix (NASDAQ:ATEXGet Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.44. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. The company had revenue of $1.96 million during the quarter, compared to the consensus estimate of $2.00 million. Sell-side analysts forecast that Anterix Inc. will post -2 EPS for the current year.

Hedge Funds Weigh In On Anterix

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Parallel Advisors LLC increased its stake in Anterix by 63.7% during the 1st quarter. Parallel Advisors LLC now owns 933 shares of the company’s stock valued at $36,000 after buying an additional 363 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Anterix by 0.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 138,677 shares of the company’s stock worth $3,027,000 after acquiring an additional 599 shares during the period. Russell Investments Group Ltd. lifted its stake in shares of Anterix by 12.4% in the 2nd quarter. Russell Investments Group Ltd. now owns 5,760 shares of the company’s stock worth $148,000 after acquiring an additional 637 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Anterix by 17.0% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,084 shares of the company’s stock valued at $182,000 after acquiring an additional 1,029 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Anterix by 299.3% in the second quarter. Tower Research Capital LLC TRC now owns 1,645 shares of the company’s stock valued at $42,000 after acquiring an additional 1,233 shares in the last quarter. Institutional investors own 87.67% of the company’s stock.

Analyst Upgrades and Downgrades

ATEX has been the subject of several recent analyst reports. Wall Street Zen downgraded Anterix from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Weiss Ratings upgraded shares of Anterix from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. DA Davidson set a $161.00 price objective on Anterix in a research report on Friday, August 21st. B. Riley Financial cut shares of Anterix from a “buy” rating to a “neutral” rating and upped their target price for the stock from $44.00 to $69.00 in a research report on Thursday, June 4th. Finally, JPMorgan Chase & Co. cut their price target on Anterix from $133.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $120.00.

Check Out Our Latest Report on Anterix

About Anterix

(Get Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Featured Articles

Insider Buying and Selling by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.